SIGNAL GRIDv0.1

Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology - CancerNetwork

1 sources1 storiesFirst seen 6/22/2026Score25Mixed Progress
Single Source
CoverageRecencyEngagementVelocityBignessConfidenceClipability
Bigness
25
Coverage
13
Recency
91
Engagement
4
Velocity
0
Confidence
49
Clipability
58
Polarization
0
Claims
3
Contradictions
0
Breakthrough
50

Sentiment Mix

Positive0%
Neutral100%
Negative0%

Geography

North America

Expert Signals

Politics - Google News CA Headlines

source1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology - CancerNetwork.

Supported by 1 story

Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology CancerNetworkShould everyone be on GLP-1s?

Supported by 1 story

What the science really tells us about cancer prevention and other benefits CBCGLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk Medical News TodayResearch shows weight-loss drugs may also reduce cancer risk PBS

Supported by 1 story

Related Events

Timeline (1 stories)

Jun 22 02:21 PMFirst
Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology - CancerNetwork
Politics - Google News CA Headlines

Receipts (1)

Bias Snapshot

Center
Left 0%Center 100%Right 0%
Blognews.google.com6/22/2026